| Identification | Back Directory | [Name]
Ritipenemacoxil | [CAS]
87238-52-6 | [Synonyms]
FCE 22891 [14C]-FCE22891 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-, (acetyloxy)methyl ester, (5R,6S)- | [Molecular Formula]
C13H16N2O8S | [MOL File]
87238-52-6.mol | [Molecular Weight]
360.34 |
| Hazard Information | Back Directory | [Uses]
Ritipenem acoxil (FCE 22891; RIPM-AC) is an oral active beta-lactamase antibiotic and can be used for study of bacterial pneumonia[1]. | [References]
[1] Saito A, et al. [A comparative study on the efficacies of ritipenem acoxil and cefotiam hexetil in bacterial pneumonia by the double-blind method]. Jpn J Antibiot. 1996 Feb;49(2):144-74. Japanese. PMID:8721077 |
| Safety Data | Back Directory | [Toxicity]
LD50 in male, female mice, male, female rats (mg/kg): 4363, 6167, >5000, >5000 orally (Brughera) |
|
|